Working… Menu

Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02527083
Recruitment Status : Completed
First Posted : August 18, 2015
Last Update Posted : October 8, 2020
Information provided by (Responsible Party):
VA Pittsburgh Healthcare System

Brief Summary:
Research suggests that the type of anesthesia used for surgery may affect intraoperative stress hormone levels. There is also data to support that an increased level of stress hormones leads to increased pain after surgery. The primary aim of this study is to determine the effect of anesthesia type on long term pain after hernia surgery. In this study, patients undergoing inguinal hernia repair will be randomized to an anesthetic group, either Total Intravenous Anesthesia (TIVA) maintained with propofol or Balanced Inhaled Anesthesia (BIA) maintained with sevoflurane. This will allow us to look at any differences in short and long-term pain after hernia repair depending on type of anesthesia received.

Condition or disease Intervention/treatment Phase
Acute Pain Chronic Pain Hernia Anesthesia, Intravenous Anesthesia, Intratracheal Drug: Propofol Drug: Sevoflurane Drug: Remifentanil Drug: Ketamine Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain
Study Start Date : January 2015
Actual Primary Completion Date : June 2019
Actual Study Completion Date : June 2019

Arm Intervention/treatment
Active Comparator: BIA
Balanced Inhalational Anesthesia (consisting of a sevoflurane inhaled anesthestic only)
Drug: Sevoflurane
Drug: Remifentanil
Active Comparator: TIVA-K
Total intravenous anesthetic with ketamine
Drug: Propofol
Drug: Ketamine
Active Comparator: TIVA-R
Total intravenous anesthetic with remifentanil
Drug: Propofol
Drug: Remifentanil

Primary Outcome Measures :
  1. Change in Chronic Pain, as measured by the Pain Quality Assessment Scale [ Time Frame: 1 month, 3 months, 6 months, 12 months ]

Secondary Outcome Measures :
  1. Change in Acute Pain, as measured by the Verbal Response Scale (0-10) [ Time Frame: Within 30 minutes after arrival to Post-Operative Care Unit (recovery unit), 1 day ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All male patients undergoing herniorrhaphy surgery that requires general anesthesia.

Exclusion Criteria:

  • Subjects unable to communicate directly with the investigators, due to being non-English speaking, loss of hearing, or incompetence.
  • A history of malignant hyperthermia, pseudocholinesterase deficiency, or other disease that prevents anesthetic randomization.
  • Pain-related disorders such as fibromyalgia or other chronic pain syndromes.
  • Emergency surgery.
Layout table for additonal information
Responsible Party: VA Pittsburgh Healthcare System Identifier: NCT02527083    
Other Study ID Numbers: PRO00000878
First Posted: August 18, 2015    Key Record Dates
Last Update Posted: October 8, 2020
Last Verified: October 2020
Additional relevant MeSH terms:
Layout table for MeSH terms
Chronic Pain
Acute Pain
Neurologic Manifestations
Peripheral Nervous System Diseases
Neuromuscular Diseases
Nervous System Diseases
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Intravenous
Anesthetics, General
Sensory System Agents
Peripheral Nervous System Agents
Anesthetics, Dissociative
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Analgesics, Opioid
Platelet Aggregation Inhibitors
Anesthetics, Inhalation